Show simple item record

dc.creatorNikolić, Stefan
dc.creatorĆirić, Ivanka
dc.creatorRoller, Alexander
dc.creatorLukeš, Vladimir
dc.creatorArion, Vladimir B.
dc.creatorGrgurić-Šipka, Sanja
dc.date.accessioned2019-06-14T11:35:08Z
dc.date.available2019-06-14T11:35:08Z
dc.date.issued2017
dc.identifier.issn1144-0546
dc.identifier.urihttp://cherry.chem.bg.ac.rs/handle/123456789/3125
dc.publisherRoyal Soc Chemistry, Cambridge
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172035/RS//
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/256716/EU//
dc.relationAustrian-Serbian mobility grant New potential anticancer drugs based on organoruthenium compounds with organic co-ligands [451-03-01039/2015-09/03, SRB-08/2016-2017]
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-sa/4.0/
dc.sourceNew Journal of Chemistry
dc.titleSupplementary data for article: Nikolić, S.; Ćirić, I.; Roller, A.; Lukeš, V.; Arion, V. B.; Grgurić-Šipka, S. Conversion of Hydrazides into: N, N ′-Diacylhydrazines in the Presence of a Ruthenium(II)-Arene Complex. New Journal of Chemistry 2017, 41 (14), 6857–6865. https://doi.org/10.1039/c7nj00965h
dc.typedataset
dc.rights.licenseBY-SA
dcterms.abstractЋирић, Иванка; Роллер, Aлеxандер; Гргурић-Шипка, Сања; Aрион, Владимир Б.; Лукеш, Владимир; Николић, Стефан;
dc.description.otherSupplementary material for: [https://doi.org/10.1039/c7nj00965h]
dc.description.otherRelated to published version: [http://cherry.chem.bg.ac.rs/handle/123456789/2485]
dc.description.otherRelated to accepted version: [http://cherry.chem.bg.ac.rs/handle/123456789/3124]
dc.type.versionpublishedVersion
dc.identifier.fulltexthttp://cherry.chem.bg.ac.rs/bitstream/id/7595/bitstream_7595.pdf


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record